J&J Units Lodge IP Suit Over Generic Concerta
Alza Corp. and Janssen Pharmaceuticals Inc. accuse Osmotica Pharmaceutical Corp.'s Hungarian unit, Osmotica Kereskedelmi es Szolgaltato Kft., of patent infringement over its filing of an abbreviated new drug application with the U.S. Food and Drug Administration. The suit asks for damages and a permanent injunction.
"Osmotica Kft.'s filing of an ANDA seeking approval to...
To view the full article, register now.